SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ethical Holdings (Ethcy) - seriously undervalued

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Preston Lurie who wrote (303)11/10/1998 8:38:00 AM
From: Joe Dancy  Read Replies (1) of 345
 
Concise summary: Elan will run the company.

New ELN approved CEO, new ELN board member, $16 million in capital injected, ELN approved business plan, renegotiated contracts for drug development, at least 7 programs that we uneconomic dropped, cuts incurred to staff, development will focus on technical feasibility and economic viability, company will be much more focused. New CEO can make changes as necessary.

Of course, ELN has the option to covert loan into 70% of the outfit, so the bad news is we are diluted. Then again, better diluted than dead.

Hard to believe that a company going public a year or so ago in London for a split adjusted $50 a share now sells for $1. Somewhat surprised that a class action lawsuit has not been filed against the company yet.

Joe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext